Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 02:15PM GMT
Release Date Price: $316.76 (-1.17%)
Juan Esteban Avendano
BofA Securities, Research Division - Associate

I'm Juan Avendano, and I am joined by my colleague, Mike Ryskin. We're part of the life sciences tools equity research team led by Derek De Bruin at Bank of America. I focus on biopharma services, mainly CROs and CDMOs. I want to thank everybody on the webcast for their participation and please feel free to submit your questions through Veracast.

It is my pleasure for me to conduct the following fireside chat with Charles River. We're joined by David Smith, their CFO; and Todd Spencer from Investor Relationships. David and Todd, thank you once again for being here.

David Ross Smith
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO

Thanks for having us.

Questions & Answers

Juan Esteban Avendano
BofA Securities, Research Division - Associate

So to set the stage and for those in the audience who might not be familiar with the product portfolio of Charles River, can you provide a quick overview of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot